AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionDempze Nancy E
Latest Disclosed Ownership6,686 shares
Latest Disclosed Value $ 1,454,138
Dempze Nancy E reports 0.07% decrease in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Dempze Nancy E filed a 13F-HR form disclosing ownership of 6,686 shares of AbbVie Inc. (BG:4AB) valued at $1,454,138 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 14, 2026 disclosing 6,691 shares of AbbVie Inc.. This represents a change in shares of -0.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 6,686 -5 -0.07 1,454 -4.84 0.1561
2026-02-14 2025-12-31 13F ABBVIE COM 00287Y109 6,691 1,192 21.68 1,529 20.03 0.7965
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 5,499 -356 -6.08 1,273 17.22 0.6993
2025-07-23 2025-06-30 13F ABBVIE COM 00287Y109 5,855 -856 -12.76 1,087 -22.76 0.6268
2025-05-06 2025-03-31 13F ABBVIE COM 00287Y109 6,711 -111 -1.63 1,406 16.01 0.8442
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 6,822 -70 -1.02 1,212 -10.95 0.7001
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 6,892 5,112 287.19 1,361 346.23 0.7593
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 1,780 667 59.93 305 50.99 0.2095
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 1,113 1,113 203 0.1543
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 0 -1,498 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 1,498 -95 -5.96 223 4.21 0.2005
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 1,593 -150 -8.61 215 -22.74 0.1840
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 1,743 -73 -4.02 278 -5.46 0.2527
2023-02-09 2022-12-31 13F ABBVIE COM 00287Y109 1,816 0 0.00 293 20.58 0.2863
2022-11-08 2022-09-30 13F ABBVIE COM 00287Y109 1,816 -55 -2.94 243 -15.03 0.2587
2022-07-19 2022-06-30 13F ABBVIE COM 00287Y109 1,871 -315 -14.41 286 -19.44 0.2873
2022-05-17 2022-03-31 13F ABBVIE COM 00287Y109 2,186 52 2.44 355 22.84 0.2593
2022-02-08 2021-12-31 13F ABBVIE COM 00287Y109 2,134 -1,105 -34.12 289 -17.19 0.1951
2021-11-10 2021-09-30 13F ABBVIE COM 00287Y109 3,239 -25 -0.77 349 -5.16 0.2738
2021-08-09 2021-06-30 13F ABBVIE COM 00287Y109 3,264 -1,421 -30.33 368 -27.42 0.3103
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 4,685 -25 -0.53 507 0.40 0.4482
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 4,710 0 0.00 505 22.57 0.4639
2020-10-28 2020-09-30 13F ABBVIE COM 00287Y109 4,710 1,078 29.68 412 15.41 0.4181
2020-07-28 2020-06-30 13F ABBVIE COM 00287Y109 3,632 0 0.00 357 28.88 0.3987
2020-05-07 2020-03-31 13F ABBVIE COM 00287Y109 3,632 -300 -7.63 277 -20.63 0.3725
2020-01-15 2019-12-31 13F ABBVIE COM 00287Y109 3,932 -40 -1.01 349 15.95 0.3863
2019-11-07 2019-09-30 13F ABBVIE COM 00287Y109 3,972 -12 -0.30 301 3.79 0.3644
2019-07-24 2019-06-30 13F ABBVIE COM 00287Y109 3,984 0 0.00 290 -9.66 0.3327
2019-05-01 2019-03-31 13F ABBVIE COM 00287Y109 3,984 0 0.00 321 -12.77 0.3786
2019-01-24 2018-12-31 13F ABBVIE COM 00287Y109 3,984 -407 -9.27 368 -11.54 0.5114
2018-10-15 2018-09-30 13F ABBVIE COM 00287Y109 4,391 -9 -0.20 416 1.96 0.4661
2018-07-30 2018-06-30 13F ABBVIE COM 00287Y109 4,400 -260 -5.58 408 -7.48 0.4989
2018-04-24 2018-03-31 13F ABBVIE COM 00287Y109 4,660 -789 -14.48 441 -16.32 0.5440
2018-02-02 2017-12-31 13F ABBVIE COM 00287Y109 5,449 2,100 62.71 527 77.44 0.6361
2017-10-26 2017-09-30 13F ABBVIE COM 00287Y109 3,349 -1,425 -29.85 297 -14.41 0.4184
2017-07-26 2017-06-30 13F ABBVIE COM 00287Y109 4,774 674 16.44 347 29.96 0.4977
2017-05-15 2017-03-31 13F ABBVIE COM 00287Y109 4,100 -555 -11.92 267 -8.56 0.4087
2017-02-14 2016-12-31 13F ABBVIE Common Stock 00287Y109 4,655 625 15.51 292 14.96 0.5116
2016-11-15 2016-09-30 13F ABBVIE Common Stock 00287Y109 4,030 0 0.00 254 2.01 0.4448
2016-08-08 2016-06-30 13F ABBVIE Common Stock 00287Y109 4,030 0 0.00 249 8.26 0.4433
2016-05-27 2016-03-31 13F ABBVIE Common Stock 00287Y109 4,030 0 0.00 230 -3.77 0.4034
2016-02-12 2015-12-31 13F ABBVIE Common Stock 00287Y109 4,030 4,030 239 0.4599
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.